Agreement signedPublished 8 Apr 2024

Windtree Therapeutics, Inc. /
Varian Biopharmaceuticals, Inc.

Windtree Therapeutics purchases Varian Biopharmaceuticals business assets

Buy side: Windtree Therapeutics, Inc.
Buy sideWindtree Therapeutics, Inc.
Target: Varian Biopharmaceuticals, Inc.
TargetVarian Biopharmaceuticals, Inc.
Source · 8 Apr 2024Source-verified
Buy side: Windtree Therapeutics, Inc.
Buy sideWindtree Therapeutics, Inc.
Target: Varian Biopharmaceuticals, Inc.
TargetVarian Biopharmaceuticals, Inc.
01 / BuyerWindtree Therapeutics, Inc.
02 / TargetVarian Biopharmaceuticals, Inc.
Source-verified
01

What happened

Windtree Therapeutics, Inc. purchased assets of Varian Biopharmaceuticals, Inc.’s business, including rights in molecules and compounds, know-how and drug-substance inventory associated with a licence agreement.

As consideration, Windtree issued 5,500 shares of Series B Convertible Preferred Stock to certain Varian creditors and agreed to pay up to $2,300,000 in milestone payments.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Windtree Therapeutics purchases Varian Biopharmaceuticals business assets

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.